Biotech startups in Copenhagen, Denmark
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| ADCendo | Copenhagen | Series C | $75.0M | 2026-04-14 |
| Again | Copenhagen | Series A | $43.1M | 2024-07-17 |
| Octarine Bio | Copenhagen | Series A | $5.9M | 2026-01-22 |
| Invert | Copenhagen | Seed | $20.1M | 2024-07-10 |
| Alcolase | Copenhagen | Seed | $1.7M | 2026-05-18 |
| SNIPR Biome | Copenhagen | Series B | $40.9M | 2025-08-07 |
| Acesion Pharma | Copenhagen | Series B | $47.6M | 2023-09-26 |
| Hedia | Copenhagen | Seed | $3.3M | 2024-02-23 |
8 rows of the CSV in 5 of its 18 columns.
- The 41 biotech startups in Copenhagen, Denmark have raised $1.2B in total.
- 9 of them closed their most recent round in the last 12 months, $205.9M combined.
- The largest of those rounds is Sidera Bio's $109.0M Series A, dated December 2025.
- The most recent is Alvara Therapeutics' $646K pre-seed round on 16 September 2026.
- Novo Holdings is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 27 companies (66%).
- 44% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (54% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 41| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Alcolase | Alcolase is a Danish life science start-up developing treatments for alcohol flushing. | Biotech | Seed | $1.7M | 2026-05-18 | $2.6M | Antler | 1 to 10 | 2021 |
| ADCendo | ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. | Biotech | Series C | $75.0M | 2026-04-14 | $324.6M | RA Capital Management, Novo Holdings, Gilde Healthcare +2 | 51 to 100 | 2017 |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. | Biotech | Series A | $5.9M | 2026-01-22 | $15.5M | MassChallenge, Vaekstfonden, Unconventional Ventures +2 | 11 to 50 | 2018 |
| SNIPR Biome | SNIPR Biome develops discovery-stage biotech treatments for microbial diseases. | Biotech | Series B | $40.9M | 2025-08-07 | $103.4M | Wellington Partners, Bill & Melinda Gates Foundation, EQT Life Sciences +1 | 11 to 50 | 2017 |
| Again | Again is a carbon utilization company that converts carbon emissions into valuable chemicals. | Biotech | Series A | $43.1M | 2024-07-17 | Google Ventures, HV Capital, ACME Capital +1 | 11 to 50 | 2020 | |
| Invert | Invert provides AI-driven software that supports real-time decisions in bioprocessing. | Artificial intelligence | Seed | $20.1M | 2024-07-10 | $20.6M | Y Combinator, Giant Ventures | 11 to 50 | 2021 |
| Hoba Therapeutics | Hoba Therapeutics develops a new therapeutic protein for treating neuropathic pain. | Biotech | Series A | $24.8M | 2023-12-11 | European Innovation Council, EIC Accelerator, Novo Holdings +2 | 1 to 10 | 2016 | |
| Labster | Labster offers virtual laboratory simulations built on mathematical algorithms for e-learning. | Biotech | Series C | $47.0M | 2022-04-04 | Andreessen Horowitz, GGV Capital, Balderton Capital +1 | 251 to 500 | 2011 |
Table 1. Biotech startups in Copenhagen, Denmark: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 41.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ADCendo | ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. | Biotech | Series C | $75.0M | 2026-04-14 | $324.6M | RA Capital Management, Novo Holdings, Gilde Healthcare +2 | 51 to 100 | 2017 |
| 2 | Octarine Bio | Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. | Biotech | Series A | $5.9M | 2026-01-22 | $15.5M | MassChallenge, Vaekstfonden, Unconventional Ventures +2 | 11 to 50 | 2018 |
| 3 | Alcolase | Alcolase is a Danish life science start-up developing treatments for alcohol flushing. | Biotech | Seed | $1.7M | 2026-05-18 | $2.6M | Antler | 1 to 10 | 2021 |
Table 2. Biotech startups in Copenhagen, Denmark: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 3 | 7% | 1 | ADCendo |
| 2 | Export and Investment Fund | Government investment office | Hellerup, Denmark | 3 | 7% | ||
| 3 | Vaekstfonden | Venture capital firm | Hellerup, Denmark | 2 | 5% | 1 | Octarine Bio |
| 4 | BioInnovation Institute Venture Lab | Startup accelerator | Copenhagen, Denmark | 2 | 5% | ||
| 5 | Gilde Healthcare | Private equity firm | Utrecht, The Netherlands | 1 | 2% | 1 | ADCendo |
| 6 | RA Capital Management | Startup incubator | Boston, United States | 1 | 2% | 1 | ADCendo |
| 7 | Pontifax | Venture capital firm | Herzliya, Israel | 1 | 2% | 1 | ADCendo |
| 8 | HealthCap | Venture capital firm | Stockholm, Sweden | 1 | 2% | 1 | ADCendo |
| 9 | Google Ventures | Corporate venture arm | San Francisco, United States | 1 | 2% | ||
| 10 | HV Capital | Venture capital firm | Munich, Germany | 1 | 2% | ||
| 11 | ACME Capital | Venture capital firm | San Francisco, United States | 1 | 2% | ||
| 12 | Oskare Capital | Venture capital firm | Paris, France | 1 | 2% | 1 | Octarine Bio |
| 13 | Unconventional Ventures | Venture capital firm | Copenhagen, Denmark | 1 | 2% | 1 | Octarine Bio |
| 14 | The Footprint Firm | Venture capital firm | Copenhagen, Denmark | 1 | 2% | 1 | Octarine Bio |
| 15 | MassChallenge | Startup accelerator | Boston, United States | 1 | 2% | 1 | Octarine Bio |
Table 3. Biotech startups in Copenhagen, Denmark: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 27 | 66% | $1.1B |
| Software | 5 | 12% | $33.8M |
| Artificial intelligence | 3 | 7% | $33.8M |
| Hardware | 2 | 5% | |
| Education | 1 | 2% |
Table 4. Biotech startups in Copenhagen, Denmark by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 9 | 22% | $646K |
| Seed | 15 | 37% | $3.3M |
| Series A | 11 | 27% | $20.6M |
| Series B | 3 | 7% | $47.6M |
| Series C | 3 | 7% | $75.0M |
Table 5. Biotech startups in Copenhagen, Denmark by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 3 | 33% | $3.7M |
| May 2026 | 1 | 11% | $1.7M |
| April 2026 | 1 | 11% | $75.0M |
| February 2026 | 1 | 11% | $4.7M |
| January 2026 | 1 | 11% | $5.9M |
| December 2025 | 2 | 22% | $114.9M |
Table 6. Biotech startups in Copenhagen, Denmark: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 17% | $91.0M |
| 2025 | 11 | 27% | $352.2M |
| 2024 | 7 | 17% | $186.1M |
| 2023 | 6 | 15% | $79.3M |
| 2022 | 4 | 10% | $48.0M |
| 2021 | 2 | 5% |
Table 7. Biotech startups in Copenhagen, Denmark by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 10 | 24% |
| 2020 to 2022 | 8 | 20% |
| 2015 to 2019 | 16 | 39% |
| 2010 to 2014 | 7 | 17% |
Table 8. Biotech startups in Copenhagen, Denmark by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 22 | 54% |
| 11 to 50 | 16 | 39% |
| 51 to 100 | 2 | 5% |
| 251 to 500 | 1 | 2% |
Table 9. Biotech startups in Copenhagen, Denmark by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Copenhagen, Denmark. On 16 November 2026 that is 41 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 41 rows: 11 have no round amount, 0 no city and 9 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Copenhagen, Denmark are on the list?
- 41, in the file dated 16 November 2026. 9 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 41 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.